Philadelphia Juries Smack J&J With $200M In Mesh Verdicts
Executive Summary
Two separate Philadelphia juries have ruled against Johnson & Johnson subsidiary Ethicon in cases brought by women who say they were injured by the company’s pelvic mesh products, awarding damages totaling $200m.
You may also be interested in...
J&J Awaits Verdict In California Pelvic Mesh Trial
An $800m lawsuit filed by the state of California against Johnson & Johnson for alleged fraudulent marketing of pelvic mesh products is in the hands of a state judge after the conclusion of a 10-week trial. This is the first lawsuit brought by a state against a pelvic mesh manufacturer to go to trial.
J&J Cleared In Philly Pelvic Mesh Trial
Product liability cases alleging manufacturers of pelvic mesh are responsible for patient injuries continued even as the US FDA is halting sales of the product. In the most recent verdict, a Philadelphia jury said Johnson & Johnson was not responsible for adverse events experienced by a Pennsylvania woman.
FDA Yanks Transvaginal Mesh From US Market; Boston Sci 'Surprised'; Firms Have 10 Days To Submit Withdraw Plan
Transvaginal mesh products made by Boston Scientific and Coloplast were ordered pulled from US shelves by the agency on Aug. 16. Under the rare FDA order, the two firms must immediately stop selling the mesh and have 10 days to submit plans to the agency outlining how they will recall their unimplanted devices.